Single Ascending Dose and Multiple Ascending Dose Phase 1 Study to determine the safety, tolerability, pharmacokinetic and pharmacodynamic parameters of PXS-4728A Administered Orally in Healthy Adult Males

Trial Profile

Single Ascending Dose and Multiple Ascending Dose Phase 1 Study to determine the safety, tolerability, pharmacokinetic and pharmacodynamic parameters of PXS-4728A Administered Orally in Healthy Adult Males

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs BI 1467335 (Primary)
  • Indications Asthma; Chronic obstructive pulmonary disease; Cystic fibrosis
  • Focus Adverse reactions; First in man
  • Sponsors Pharmaxis
  • Most Recent Events

    • 08 Jun 2016 Last checked against Australian New Zealand Clinical Trials Registry record.
    • 21 Sep 2015 Positive results published in Pharmaxis media release.
    • 13 Aug 2015 Status changed from active, no longer recruiting to completed as per Australian New Zealand Clinical Trials Registry record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top